|
|
Volumn 112, Issue 1, 2013, Pages 6-8
|
|
Early cardiac retention of administered stem cells determines clinical efficacy of cell therapy in patients with dilated cardiomyopathy.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD34 ANTIGEN;
CONGESTIVE CARDIOMYOPATHY;
FEMALE;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE;
HUMAN;
IMMUNOLOGY;
MALE;
METABOLISM;
NOTE;
PATHOLOGY;
STEM CELL;
STEM CELL TRANSPLANTATION;
ANTIGENS, CD34;
CARDIOMYOPATHY, DILATED;
FEMALE;
HUMANS;
MALE;
MYOCARDIUM;
STEM CELL TRANSPLANTATION;
STEM CELLS;
VENTRICULAR FUNCTION, LEFT;
|
|
EID: 84874409958
PISSN: None
EISSN: 15244571
Source Type: Journal
DOI: 10.1161/CIRCRESAHA.112.300341 Document Type: Note |
|
Times cited : (14)
|
|
References (0)
|
